{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:21:20Z","timestamp":1790014880157,"version":"4.0.1"},"reference-count":54,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Expression of the lytic cycle genes of Epstain-Barr virus (EBV) is induced in type I Burkitt's lymphoma-derived cells by treatment with phorbol esters (e.g., phorbol myristate acetate [PMA]), anti-immunoglobulin, or the cytokine transforming growth factor \u03b2 (TGF-\u03b2). Concomitantly, all these agents induce apoptosis as judged by a sub-G<jats:sub>1<\/jats:sub>fluorescence-activated cell sorter (FACS) profile, proteolytic cleavage of poly(ADP-ribose) polymerase (PARP) and terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) staining. However, caspase activation is not required for induction of the lytic cycle since the latter is not blocked by the caspase inhibitor ZVAD. Furthermore, not all agents that induce apoptosis in these cultures (for example, cisplatin and ceramide) induce the EBV lytic programme. Although it is closely associated with the lytic cycle, apoptosis is neither necessary nor sufficient for its activation. Multiparameter FACS analysis of cultures treated with PMA, anti-Ig, or TGF-\u03b2 revealed BZLF1-expressing cells distributed in different phases of the cell cycle according to which inducer was used. However, BZLF1-positive cells did not appear to undergo apoptosis and accumulate with a sub-G<jats:sub>1<\/jats:sub>DNA content, irrespective of the inducer used. This result, which suggests that lytic gene expression is protective, was confirmed and extended by immunofluorescence staining doubled with TUNEL analysis. BZLF1- and also gp350-expressing cells were almost always shown to be negative for TUNEL staining. Similar experiments using EBV-positive and -negative subclones of Akata BL cells carrying an episomal BZLF1 reporter plasmid confirmed that protection from apoptosis was associated with the presence of the EBV genome. Finally, treatment with phosphonoacetic acid or acyclovir prior to induction with PMA, anti-Ig, or TGF-\u03b2 blocked the protective effect in Mutu-I cells. These data suggest that a late gene product(s) may be particularly important for protection against caspase activity and cell death.<\/jats:p>","DOI":"10.1128\/jvi.75.5.2400-2410.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:55:53Z","timestamp":1027763753000},"page":"2400-2410","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":60,"title":["Activators of the Epstein-Barr Virus Lytic Program Concomitantly Induce Apoptosis, but Lytic Gene Expression Protects from Cell Death"],"prefix":"10.1128","volume":"75","author":[{"given":"Gareth J.","family":"Inman","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich K.","family":"Binne\u0301","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A.","family":"Parker","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Farrell","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Allday","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"55","article-title":"Apoptosis and Epstein-Barr virus in B cells","volume":"3","author":"Allday M. J.","year":"1996","unstructured":"Allday M. J. Apoptosis and Epstein-Barr virus in B cells.Epstein-Barr Rep. 3 1996 55 65","journal-title":"Epstein-Barr Rep."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80622-6"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.4.567"},{"key":"e_1_3_2_5_2","first-page":"1141","article-title":"Epstein-Barr virus induction by a serum factor. Characterisation of the purified factor and the mechanism of its activation","volume":"257","author":"Bauer G.","year":"1982","unstructured":"Bauer G. Hofler P. Simon M. Epstein-Barr virus induction by a serum factor. Characterisation of the purified factor and the mechanism of its activation.J. Biol. Chem. 257 1982 1141 11415","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.12.4085"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.7.3358-3369.1990"},{"key":"e_1_3_2_8_2","first-page":"1615","article-title":"Characterization of transforming growth factor beta-1 induced apoptosis in normal human B cells B lymphoma cell lines","volume":"11","author":"Chaouchi N.","year":"1995","unstructured":"Chaouchi N. Arvanitakis L. Auffredou M. T. Blanchard D. A. Vasquez A. Sharma S. Characterization of transforming growth factor beta-1 induced apoptosis in normal human B cells B lymphoma cell lines.Oncogene 11 1995 1615 1622","journal-title":"Oncogene"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1986.tb04635.x"},{"key":"e_1_3_2_10_2","first-page":"609","article-title":"Cloning and structural analysis of cDNAs for bcl2 and a hybrid bcl2\/immunoglobulin transcript resulting from the t14;18 translocation","volume":"74","author":"Cleary M. L.","year":"1986","unstructured":"Cleary M. L. Smith S. Sklar J. Cloning and structural analysis of cDNAs for bcl2 and a hybrid bcl2\/immunoglobulin transcript resulting from the t14;18 translocation.Cell 74 1986 609 619","journal-title":"Cell"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.12.6838-6844.1991"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1994.1056"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910570623"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.68.1.383"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.13.5810-5818.2000"},{"key":"e_1_3_2_16_2","first-page":"120","article-title":"Epstein-Barr virus","volume":"1","author":"Farrell P. J.","year":"1993","unstructured":"Farrell P. J. Epstein-Barr virus Genetic maps O.'Brien S. 1 1993 120 129 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y","journal-title":"Genetic maps"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03356.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.3.1227-1232.1990"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.3.1217-1226.1990"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/349612a0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","article-title":"Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype","volume":"139","author":"Gregory C. D.","year":"1987","unstructured":"Gregory C. D. Tursz T. Edwards C. F. Tetaud C. Talbot M. Caillou B. Rickinson A. B. Lipinski M. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.J. Immunol. 139 1987 313 318","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.18.8479"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.5.2979"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.5.2500"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-6-1567"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.2.710-720.2000"},{"key":"e_1_3_2_27_2","unstructured":"Kieff E. Epstein-Barr virus and its replication P. 2343\u20132396.Fields virology. Fields B. N. Knipe D. M. Howley P. M. 1996 Lippincott-Raven Philadelphia Pa"},{"key":"e_1_3_2_28_2","unstructured":"Kornberg A. Baker T. DNA replication (2nd ed.) W. H. 1992 Freeman and Co. New York N.Y"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.3.1143-1155.1990"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.3.1147.bloodjournal8731147"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03576.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.11.5991-6000.1991"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.6.5181-5185.1999"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.6.627"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90513-8"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203327"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(87)90055-9"},{"key":"e_1_3_2_38_2","unstructured":"Rickinson A. B. Kieff E. Epstein-Barr virus Fields virology. Fields B. N. Knipe D. M. Howley P. M. 1996 2397 2446 Lippincott-Raven Philadelphia Pa"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.11.9029-9038.1999"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.1.122-131.1992"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02568.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.6.3240-3245.1993"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.9.6069-6073.1994"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(97)01129-3"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.8.6540-6550.1999"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910330106"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.1.445-449.1989"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1994.1309"},{"key":"e_1_3_2_49_2","first-page":"158","article-title":"EBV: schizophrenic but not disfunctional","volume":"6","author":"Thorley-Lawson D. A.","year":"1999","unstructured":"Thorley-Lawson D. A. EBV: schizophrenic but not disfunctional.Epstein-Barr Rep. 6 1999 158 163","journal-title":"Epstein-Barr Rep."},{"key":"e_1_3_2_50_2","first-page":"373","article-title":"Activation of latent Epstein-Barr virus by antibody to human IgM","volume":"272","author":"Tovey M.","year":"1978","unstructured":"Tovey M. Lenoir G. Lours-Begon J. Activation of latent Epstein-Barr virus by antibody to human IgM.Nature (London) 272 1978 373 375","journal-title":"Nature (London)"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03527.x"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.7.3908-3916.1993"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.4.1344-1360.2000"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.6.2868-2874.1991"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/272373a0"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.5.2400-2410.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.5.2400-2410.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T14:45:04Z","timestamp":1682261104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.75.5.2400-2410.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1128\/JVI.75.5.2400-2410.2001"],"URL":"https:\/\/doi.org\/10.1128\/jvi.75.5.2400-2410.2001","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2000-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-11-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}